{
    "2019-09-02": [
        [
            {
                "time": "",
                "original_text": "贝达药业：正递交盐酸恩沙替尼药品注册临床试验数据更新补充材料",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "盐酸恩沙替尼",
                        "药品注册",
                        "临床试验",
                        "数据更新",
                        "补充材料"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}